Literature DB >> 31040092

Serum alanine transaminase levels predict type 2 diabetes risk among a middle-aged and elderly Chinese population.

Yaru Li1, Jing Wang1, Xu Han1, Hua Hu1, Fei Wang1, Caizheng Yu1, Jing Yuan1, Ping Yao1, Xiulou Li2, Kun Yang2, Xiaoping Miao1, Sheng Wei1, Youjie Wang1, Weihong Chen1, Yuan Liang1, Xiaomin Zhang1, Huan Guo1, Handong Yang2, Tangchun Wu1, Meian He3.   

Abstract

INTRODUCTION AND AIM: It is indicated that high levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are associated with increased incident type 2 diabetes risk. However, whether serum ALT levels could improve the discrimination of type 2 diabetes remains unclear.
METHODS: The data was derived from the Dongfeng-Tongji cohort study, which was established in 2008 and followed until October 2013. A total of 17,173 participants free of type 2 diabetes at baseline were included and 1159 participants developed diabetes after 4.51 (0.61) years of follow-up. Cox proportional hazard regression model was used to calculate the hazard ratios (HRs) for the association between ALT and AST levels with incident diabetes risk. Receiver-operating characteristic (ROC) curves analysis was used to evaluate the predictive accuracy of models incorporating traditional risk factors with and without ALT.
RESULTS: Compared with the lowest quartile of ALT and AST levels, the highest quartile had a significantly higher risk of developing type 2 diabetes (HR: 2.17 [95% CI: 1.78-2.65] and 1.29 [1.08-1.54], respectively) after adjustment for potential confounders. The addition of ALT levels into the traditional risk factors did not improve the predictive ability of type 2 diabetes, with AUC increase from 0.772 to 0.774; P=0.86.
CONCLUSIONS: Although elevated ALT or AST levels increased incident type 2diabetes risk, addition of ALT levels into the prediction model did not improve the discrimination of type 2 diabetes.
Copyright © 2019 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Alanine aminotransferase; Prediction model; Type 2 diabetes

Mesh:

Substances:

Year:  2019        PMID: 31040092     DOI: 10.1016/j.aohep.2017.02.001

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  2 in total

1.  Considering serum alanine aminotransferase and gamma-glutamyltransferase levels together strengthen the prediction of impaired fasting glucose risk: a cross-sectional and longitudinal study.

Authors:  Ji Hye Jeong; Susie Jung; Kyu-Nam Kim
Journal:  Sci Rep       Date:  2021-02-09       Impact factor: 4.379

2.  Combined effect of serum alanine aminotransferase and gamma-glutamyltransferase on incidence of diabetes mellitus: A longitudinal study.

Authors:  Sung-Hyun Choi; Bom-Taeck Kim; Junghwa Shin; Kyu-Nam Kim
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.